Cleared Traditional

ABUSCREEN RADIOIMMUNOASSAY-AMPHETAMINE

K830482 · Hoffmann-La Roche, Inc. · Toxicology
Mar 1983
Decision
37d
Days
Class 2
Risk

About This 510(k) Submission

K830482 is an FDA 510(k) clearance for the ABUSCREEN RADIOIMMUNOASSAY-AMPHETAMINE, a Radioimmunoassay, Amphetamine (Class II — Special Controls, product code DJP), submitted by Hoffmann-La Roche, Inc. (Walker, US). The FDA issued a Cleared decision on March 24, 1983, 37 days after receiving the submission on February 15, 1983. This device falls under the Toxicology review panel. Regulated under 21 CFR 862.3100.

Submission Details

510(k) Number K830482 FDA.gov
FDA Decision Cleared SESE
Date Received February 15, 1983
Decision Date March 24, 1983
Days to Decision 37 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary —

Device Classification

Product Code DJP — Radioimmunoassay, Amphetamine
Device Class Class II — Special Controls
CFR Regulation 21 CFR 862.3100

Similar Devices — DJP Radioimmunoassay, Amphetamine

All 8
PRIMIDONE EIA TEST
K960526 · Diagnostic Reagents, Inc. · Mar 1996
URINE AMPHETAMINE DIRECT RIA KIT (I-125)
K913866 · Immunalysis Corporation · Sep 1991
ABUSCREEN RADIOIMMUNOASSAY FOR AMPHETAMINE
K912755 · Roche Diagnostic Systems, Inc. · Aug 1991
REVISED DOUBLE ANTIBODY AMPHETAMINE
K882228 · Diagnostic Products Corp. · Aug 1988
ABUSCREEN(R) ONTRAK(TM) FOR AMPHETAMINES
K881817 · Roche Diagnostic Systems, Inc. · Jul 1988
ABUSCREEN RADIOIMMUNOASSAY FOR AMPHETAMINE-HIGH SP
K854009 · Roche Diagnostic Systems, Inc. · Oct 1985